RxDoctor Payments Data

Derek Higgins, DO

Physical Medicine & Rehabilitation · Gilbert, AZNPI 1568611655

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Medtronic at 37.4% of the total. Reporting peaked in 2020 at $1,307 and has fallen 91.3% since, to $114 in 2025.

$3,611in general payments, 2019–2025

Across 83 payments — averaging $43.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Nevro Corp.$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$215
  • Collegium Pharmaceutical, Inc.$137
  • Almatica Pharma LLC$121
  • Stimwave Technologies Incorporated$109
  • plus $544 from 20 others

What the payments were for

  • Speaking & faculty fees$1,89252%
  • Food & beverage$1,66146%
  • Education$592%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)15$1,352
Nevro Corp.8$1,133
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$215
Collegium Pharmaceutical, Inc.10$137
Almatica Pharma LLC8$121
Stimwave Technologies Incorporated1$109
Protega Pharmaceutials Inc2$72
Piramal Critical Care4$61
Scilex Pharmaceuticals Inc.1$48
Biodelivery Sciences International, Inc.3$42
SPR Therapeutics, Inc1$37
Redhill Biopharma Inc.2$33
Virtus Pharmaceuticals LLC2$30
Angiodynamics, Inc.1$28
Otto Bock Healthcare LP1$23
Vertos Medical, Inc.1$23
Shionogi Inc1$21
Boston Scientific1$17
Emergent Biosolutions Inc.1$17
Bioventus LLC1$16
Metacel Pharmaceuticals LLC1$14
Orthogenrx Inc.1$13
Arbor Pharmaceuticals, Inc.1$13
Tersera Therapeutics LLC1$12
AstraZeneca1$12
Zyla Life Sciences, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,611 in reported general payments places this provider in the 85th percentile of 162 physical medicine & rehabilitation providers in Arizona.

See all physical medicine & rehabilitation providers in Arizona

Medicare billing

Part B allowed, 2024
$459,910
Medicare patients
658
Services billed
65,412

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen62$2,293
Fentanyl11$1,604
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen69$1,550
Gabapentin49$1,446
Oxycodone Hcl73$1,168
Baclofen20$624
Pregabalin36$624
Hydromorphone Hcl18$436
Tizanidine Hcl16$384
Methocarbamol13$363
Celecoxib12$342
Morphine Sulfate ErMorphine Sulfate19$325
Cyclobenzaprine Hcl26$243
Tramadol Hcl36$216
Trazodone Hcl12$96

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Gilbert

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →